CoChat

Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers

Open access
Stickel, Felix, Lutz, Philipp, Buch, Stephan, Nischalke, Hans Dieter, Silva, Ines, Rausch, Vanessa, Fischer, Janett, Weiss, Karl Heinz, Gotthardt, Daniel, Rosendahl, Jonas, Marot, Astrid, Elamly, Mona, Krawczyk, Marcin, Casper, Markus, Lammert, Frank, Buckley, Thomas W. M., McQuillin, Andrew, Spengler, Ulrich, Eyer, Florian, Vogel, Arndt, Marhenke, Silke, von Felden, Johann, Wege, Henning, Sharma, Rohini, Atkinson, Stephen, Franke, Andre, Nehring, Sophie, Moser, Vincent, Schafmayer, Clemens, Spahr, Laurent, Lackner, Carolin, Stauber, Rudolf E., Canbay, Ali, Link, Alexander, Valenti, Luca, Grove, Jane I., Aithal, Guruprasad P., Marquardt, Jens U., Fateen, Waleed, Zopf, Steffen, Dufour, Jean‐Francois, Trebicka, Jonel, Datz, Christian, Deltenre, Pierre, Mueller, Sebastian, Berg, Thomas, Hampe, Jochen, Morgan, Marsha Y. · 2020 · Hepatology
Cited by 108

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background and Aims: Carriage of rs738409:G in patatin‐like phospholipase domain containing 3 (PNPLA3) is associated with an increased risk for developing alcohol‐related cirrhosis and hepatocellular carcinoma (HCC). Recently, rs72613567:TA in hydroxysteroid 17‐beta dehydrogenase 13 (HSD17B13) was shown to be associated with a reduced risk for developing alcohol‐related liver disease and to attenuate the risk associated with carriage of PNPLA3 rs738409:G. This study explores the risk associations between these two genetic variants and the development of alcohol‐related cirrhosis and HCC. Approach and Results: Variants in HSD17B13 and PNPLA3 were genotyped in 6,171 participants, including 1,031 with alcohol‐related cirrhosis and HCC, 1,653 with alcohol‐related cirrhosis without HCC, 2,588 alcohol misusers with no liver disease, and 899 healthy controls. Genetic associations with the risks for developing alcohol‐related cirrhosis and HCC were determined using logistic regression analysis. Carriage of HSD17B13 rs72613567:TA was associated with a lower risk for developing both cirrhosis (odds ratio [OR], 0.79; 95% confidence interval [CI], 0.72‐0.88; P = 8.13 × 10−6) and HCC (OR, 0.77; 95% CI, 0.68‐0.89; P = 2.27 × 10−4), whereas carriage of PNPLA3 rs738409:G was associated with an increased risk for developing cirrhosis (OR, 1.70; 95% CI, 1.54‐1.88; P = 1.52 × 10−26) and HCC (OR, 1.77; 95% CI, 1.58‐1.98; P = 2.31 × 10−23). These associations remained significant after adjusting for age, sex, body mass index, type 2 diabetes, and country. Carriage of HSD17B13 rs72613567:TA attenuated the risk for developing cirrhosis associated with PNPLA3 rs738409:G in both men and women, but the protective effect against the subsequent development of HCC was only observed in men (OR allelic, 0.75; 95% CI, 0.64‐0.87; P = 1.72 × 10−4). Conclusions: Carriage of variants in PNPLA3 and HSD17B13 differentially affect the risk for developing advanced alcohol‐related liver disease. A genotypic/phenotypic risk score might facilitate earlier diagnosis of HCC in this population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.30996

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 108

Metadata

Authors
Stickel, F., Lutz, P., Buch, S., Nischalke, H. D., Silva, I., Rausch, V., Fischer, J., Weiss, K. H., Gotthardt, D., Rosendahl, J., Marot, A., Elamly, M., Krawczyk, M., Casper, M., Lammert, F., Buckley, T. W. M., McQuillin, A., Spengler, U., Eyer, F., Vogel, A., Marhenke, S., von Felden, J., Wege, H., Sharma, R., Atkinson, S., Franke, A., Nehring, S., Moser, V., Schafmayer, C., Spahr, L., Lackner, C., Stauber, R. E., Canbay, A., Link, A., Valenti, L., Grove, J. I., Aithal, G. P., Marquardt, J. U., Fateen, W., Zopf, S., Dufour, J., Trebicka, J., Datz, C., Deltenre, P., Mueller, S., Berg, T., Hampe, J., & Morgan, M. Y.
Venue
Hepatology
Published
2020-05-20
Volume
72
Issue
1
Pages
88-102
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2980926085
Cited by
108
References
10
FWCI
10.48
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers. https://app.cochat.ai/papers/10.1002/hep.30996
The paper
Stickel, F., Lutz, P., Buch, S., Nischalke, H. D., Silva, I., Rausch, V., Fischer, J., Weiss, K. H., Gotthardt, D., Rosendahl, J., Marot, A., Elamly, M., Krawczyk, M., Casper, M., Lammert, F., Buckley, T. W. M., McQuillin, A., Spengler, U., Eyer, F., . . . Morgan, M. Y. (2020). Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers. Hepatology. https://doi.org/10.1002/hep.30996

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.